Prelude Capital Management, LLC Gilead Sciences, Inc. Call Options Transaction History

Prelude Capital Management, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2020 Feb 16, 2021	BUY	$56.65 - $64.55 $997,040 - $1.14 Million	17,600 Added 345.1%	22,700 $1.32 Million
Q2 2020 Aug 14, 2020	BUY	$72.34 - $84.0 $339,998 - $394,800	4,700 Added 1175.0%	5,100 $392,000
Q1 2020 May 15, 2020	SELL	$62.63 - $80.22 $31,315 - $40,110	-500 Reduced 55.56%	400 $30,000
Q4 2019 Feb 14, 2020	BUY	$61.62 - $67.78 $30,810 - $33,890	500 Added 125.0%	900 $58,000
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $25,012 - $28,020	400 New	400 $26,000

1,926

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $111B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.